Fidelity Investments’s PAVmed PAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Hold
0
-$4 5612
2023
Q4
Hold
0
5381
2023
Q3
Hold
0
5053
2023
Q2
Sell
-1
Closed -$187 5542
2023
Q1
$187 Hold
1
﹤0.01% 4859
2022
Q4
$177 Sell
1
-1
-50% -$378 ﹤0.01% 4838
2022
Q3
$1K Sell
2
-6
-75% -$3.4K ﹤0.01% 4720
2022
Q2
$4K Buy
8
+5
+167% +$2.42K ﹤0.01% 4388
2022
Q1
$2K Buy
+3
New +$2.23K ﹤0.01% 4692
2021
Q4
Sell
-3,140
Closed -$12.1M 4781
2021
Q3
$12.1M Buy
3,140
+30
+1% +$94.6K ﹤0.01% 2048
2021
Q2
$8.96M Sell
3,110
-1
-0% -$2.36K ﹤0.01% 2155
2021
Q1
$6.22M Buy
+3,111
New +$4.68M ﹤0.01% 2194

Other funds holding PAVM

Fidelity Investments's PAVM Position: Q1 2024 in Review

Fidelity Investments held its PAVmed (PAVM) position steady in Q1 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5612.

Fidelity Investments first reported a position in PAVM in Q1 2021 and has held it in 8 quarters since. The position peaked at $12.1M in Q3 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2024.

  • Fidelity Investments held 0 shares of PAVmed worth $0 as of Q1 2024.
  • Fidelity Investments left its PAVmed share count unchanged in Q1 2024.
  • PAVmed made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2024, its #5612 holding.
  • Fidelity Investments first reported a position in PAVmed in Q1 2021 and has held it in 8 quarters since.
  • Fidelity Investments's PAVmed position peaked at $12.1M in Q3 2021.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2024.

Based on Fidelity Investments's 13F filing for Q1 2024, filed 13 May 2024.